Skip to Content
Merck
CN

G8887

Glucokinase from Bacillus stearothermophilus

lyophilized powder, ≥250 units/mg protein

Synonym(s):

ATP:D-glucose-6-phosphotransferase

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

CAS Number:
EC Number:
UNSPSC Code:
12352204
MDL number:
Specific activity:
≥250 units/mg protein
Biological source:
Bacillus sp. (B. stearothermophilus)
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


biological source

Bacillus sp. (B. stearothermophilus)

Quality Level

form

lyophilized powder

specific activity

≥250 units/mg protein

composition

Protein, ≥60% biuret

shipped in

dry ice

storage temp.

−20°C

Physical form

Lyophilized powder containing Tris buffer salts

Other Notes

One unit will phosphorylate 1.0 μmole of D-glucose to D-glucose 6-phosphate per min at pH 9.0 at 30 °C.


Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Regulatory Information

常规特殊物品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



David Callejas et al.
Diabetes, 62(5), 1718-1729 (2013-02-05)
Diabetes is associated with severe secondary complications, largely caused by poor glycemic control. Treatment with exogenous insulin fails to prevent these complications completely, leading to significant morbidity and mortality. We previously demonstrated that it is possible to generate a "glucose
Lei Zhang et al.
European journal of medicinal chemistry, 58, 624-639 (2012-11-28)
Dual-target-directed agents simultaneously inhibiting glycogen phosphorylase (GP) and activating glucokinase (GK) could decelerate the inflow of glucose from glycogenolysis and accelerate the outflow of glucose in the liver, therefore allow for a better control over hyperglycaemia in a synergetic manner.
Response to Comment on: Chakera et al. Antenatal diagnosis of fetal genotype determines if maternal hyperglycemia due to a glucokinase mutation requires treatment. Diabetes Care 2012;35:1832-1834.
Ali J Chakera et al.
Diabetes care, 36(1), e15-e15 (2012-12-25)



Global Trade Item Number

SKUGTIN
G8887-500UN04061833649961
G8887-250UN04061833649954
G8887-100UN04061833649947